Growth Metrics

TriSalus Life Sciences (TLSI) Receivables - Net (2022 - 2025)

Historic Receivables - Net for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $5.0 million.

  • TriSalus Life Sciences' Receivables - Net rose 179.15% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 179.15%. This contributed to the annual value of $5.1 million for FY2024, which is 4130.56% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Receivables - Net stood at $5.0 million, which was up 179.15% from $5.6 million recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Receivables - Net peaked at $5.6 million during Q2 2025, and registered a low of $1.6 million during Q4 2022.
  • In the last 4 years, TriSalus Life Sciences' Receivables - Net had a median value of $4.8 million in 2024 and averaged $4.3 million.
  • Per our database at Business Quant, TriSalus Life Sciences' Receivables - Net surged by 13121.39% in 2023 and then soared by 179.15% in 2025.
  • Over the past 4 years, TriSalus Life Sciences' Receivables - Net (Quarter) stood at $1.6 million in 2022, then skyrocketed by 131.21% to $3.6 million in 2023, then skyrocketed by 41.31% to $5.1 million in 2024, then dropped by 1.71% to $5.0 million in 2025.
  • Its Receivables - Net stands at $5.0 million for Q3 2025, versus $5.6 million for Q2 2025 and $5.5 million for Q1 2025.